Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Koichi Kimura, Koji Hayashi, Mamiko Sato, Yuka Nakaya, Asuka Suzuki, Naoko Takaku, Hiromi Hayashi, Kouji Hayashi, Toyoaki Miura, Yasutaka Kobayashi

Open source

DOI
10.3390/diagnostics15212723
Published
2025-10-27
Container
Diagnostics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/diagnostics15212723,
  title = {Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD)},
  author = {Koichi Kimura and Koji Hayashi and Mamiko Sato and Yuka Nakaya and Asuka Suzuki and Naoko Takaku and Hiromi Hayashi and Kouji Hayashi and Toyoaki Miura and Yasutaka Kobayashi},
  year = {2025},
  journal = {Diagnostics},
  doi = {10.3390/diagnostics15212723},
  url = {https://doi.org/10.3390/diagnostics15212723}
}

RIS

TY  - JOUR
TI  - Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD)
AU  - Koichi Kimura
AU  - Koji Hayashi
AU  - Mamiko Sato
AU  - Yuka Nakaya
AU  - Asuka Suzuki
AU  - Naoko Takaku
AU  - Hiromi Hayashi
AU  - Kouji Hayashi
AU  - Toyoaki Miura
AU  - Yasutaka Kobayashi
PY  - 2025
JO  - Diagnostics
DO  - 10.3390/diagnostics15212723
UR  - https://doi.org/10.3390/diagnostics15212723
ER  - 

APA

Kimura, K., Hayashi, K., Sato, M., Nakaya, Y., Suzuki, A., Takaku, N., Hayashi, H., Hayashi, K., Miura, T., & Kobayashi, Y. (2025). Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD). Diagnostics. https://doi.org/10.3390/diagnostics15212723

Source records